Cartilage-Specific Ablation of XBP1 Signaling in Mouse Results in a Chondrodysplasia Characterized by Reduced Chondrocyte Proliferation and Delayed Cartilage Maturation and Mineralization by Cameron TL et al.
Osteoarthritis and Cartilage 23 (2015) 661e670Cartilage-specific ablation of XBP1 signaling in mouse results in a
chondrodysplasia characterized by reduced chondrocyte proliferation
and delayed cartilage maturation and mineralization
T.L. Cameron y, I.L. Gresshoff y, K.M. Bell y, K.A. Pirog z, L. Sampurno y, C.L. Hartley x,
E.M. Sanford y, R. Wilson y, J. Ermann k ¶, R.P. Boot-Handford #, L.H. Glimcher yy,
M.D. Briggs z, J.F. Bateman y zz *
y Murdoch Childrens Research Institute, Parkville, Victoria, Australia
z Institute of Genetic Medicine, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK
x Central Manchester University Hospitals NHS Foundation Trust, St Mary's Hospital, Manchester, UK
k Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, USA
¶ Harvard Medical School, Boston, MA, USA
# Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, The University of Manchester, Manchester, UK
yy Weill Cornell Medical College, Cornell University, New York, NY, USA
zz Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australiaa r t i c l e i n f o
Article history:
Received 21 July 2014






XBP1* Address correspondence and reprint requests to: J
6422.
E-mail addresses: trevor.cameron@mcri.edu.au (T
newcastle.ac.uk (K.A. Pirog), lisa.sampurno@mcri.edu
wilson@utas.edu.au (R. Wilson), jermann@partners.o
michael.briggs@newcastle.ac.uk (M.D. Briggs), john.ba
http://dx.doi.org/10.1016/j.joca.2015.01.001
1063-4584/© 2015 Osteoarthritis Research Society Ins u m m a r y
Objective: To investigate the in vivo role of the IRE1/XBP1 unfolded protein response (UPR) signaling
pathway in cartilage.
Design: Xbp1flox/flox.Col2a1-Cre mice (Xbp1CartDEx2), in which XBP1 activity is ablated specifically from
cartilage, were analyzed histomorphometrically by Alizarin red/Alcian blue skeletal preparations and X-
rays to examine overall bone growth, histological stains to measure growth plate zone length, chon-
drocyte organization, and mineralization, and immunofluorescence for collagen II, collagen X, and IHH.
Bromodeoxyuridine (BrdU) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)
analyses were used to measure chondrocyte proliferation and cell death, respectively. Chondrocyte
cultures and microdissected growth plate zones were analyzed for expression profiling of chondrocyte
proliferation or endoplasmic reticulum (ER) stress markers by Quantitative PCR (qPCR), and of Xbp1
mRNA splicing by RT-PCR to monitor IRE1 activation.
Results: Xbp1CartDEx2 displayed a chondrodysplasia involving dysregulated chondrocyte proliferation,
growth plate hypertrophic zone shortening, and IRE1 hyperactivation in chondrocytes. Deposition of
collagens II and X in the Xbp1CartDEx2 growth plate cartilage indicated that XBP1 is not required for matrix
protein deposition or chondrocyte hypertrophy. Analyses of mid-gestation long bones revealed delayed
ossification in Xbp1CartDEx2 embryos. The rate of chondrocyte cell death was not significantly altered, and
only minimal alterations in the expression of key markers of chondrocyte proliferation were observed in
the Xbp1CartDEx2 growth plate. IRE1 hyperactivation occurred in Xbp1CartDEx2 chondrocytes but was not
sufficient to induce regulated IRE1-dependent decay (RIDD) or a classical UPR.
Conclusion: Our work suggests roles for XBP1 in regulating chondrocyte proliferation and the timing of
mineralization during endochondral ossification, findings which have implications for both skeletal
development and disease.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved..F. Bateman, Murdoch Childrens Research Institute, Flemington Road, Parkville, Victoria 3052, Australia. Tel: 61-3-8341-
.L. Cameron), irma.gresshoff@unimelb.edu.au (I.L. Gresshoff), katrina.bell@mcri.edu.au (K.M. Bell), katarzyna.pirog@
.au (L. Sampurno), claire.burgoyne@cmft.nhs.uk (C.L. Hartley), emma.sanford@mcri.edu.au (E.M. Sanford), richard.
rg (J. Ermann), ray.boot-handford@manchester.ac.uk (R.P. Boot-Handford), lglimche@med.cornell.edu (L.H. Glimcher),
teman@mcri.edu.au (J.F. Bateman).
ternational. Published by Elsevier Ltd. All rights reserved.
T.L. Cameron et al. / Osteoarthritis and Cartilage 23 (2015) 661e670662Introduction
Endochondral ossification is regulated in the cartilage growth
plate, where chondrocytes secrete an elaborate extracellular matrix
(ECM) and differentiate by proliferation and hypertrophy to drive
longitudinal bone growth. Owing to the burden placed on the
endoplasmic reticulum (ER) by the production of cartilage ECM
components, chondrocytes rely on the unfolded protein response
(UPR) to maintain ER homeostasis1,2.
The UPR is regulated by ER membrane-spanning proteins
including IRE1, ATF6, and PERK. These ER stress sensors reduce ER
protein load by activating molecular pathways that increase the ca-
pacity of the ER to fold nascent proteins correctly and to eradicate
chronically misfolded proteins, and reduce the overall rate of protein
translation3. Several other ER sensors that are structurally and func-
tionally homologous to ATF6 have also been described1. For cartilage
development, the most important of these appears to be BBF2H7.
Deletion of Bbf2h7 causes a severe chondrodysplasia resulting from
chondrocyte ER stress caused by impaired intracellular trafficking of
secreted proteins2. Also important is ATF4, a transcription factor
expressed following ER stress-induced activation of PERK. ATF4
controls chondrocyte proliferation and growth plate mineralization
by regulating expression of IHH, and like BBF2H7 its ablation results
in a dramatic chondrodysplasia4. Together these studies emphasize
the importance of chondrocyte ER homeostasis for cartilage devel-
opment. IRE1 signaling in cartilage development in vivo has not been
investigated. IRE1 activation by ER stress results in the unconven-
tional splicing of XBP1 mRNA to encode a transcription factor that
drives the expression of UPR target genes. IRE1 also acts indepen-
dently of XBP1 in a rapid response to ER stress known as regulated
IRE1-dependent decay (RIDD), degrading a subset of transcripts
encoding proteins normally processed via the ER5.
XBP1 regulates several developmental processes involving pro-
fessional secretory cells6, and may also regulate cartilage develop-
ment7. It was reported recently that spliced XBP1 (XBP1S) was
expressed in the mouse growth plate and during chondrogenic
differentiation in vitro. Moreover, over-expression of XBP1S in these
studies accelerated chondrocyte hypertrophy and the expression of
Ihh,Col10a1, andRunx2, aswell as Pthrp, while knockdownabolished
hypertrophy and the expression of these genes. These data sug-
gested that XBP1 may be required for chondrocyte hypertrophy by
affecting IHH/PTHrP signaling and acting as a co-factor of RUNX27.
To determine if the XBP1 pathway controls chondrocyte hy-
pertrophy in vivo we generated and characterized mice in which
XBP1 was functionally inactivated by deletion of exon 2 in cartilage
(Xbp1CartDEx2). We demonstrate that cartilage-specific ablation of
XBP1 activity does not prevent chondrocyte hypertrophy in vivo, in
contrast to predictions from in vitro data7, but causes a chon-
drodysplasia phenotype involving shortening of endochondral
bones and delayed endochondral ossification during development,
but which resolves by skeletal maturity. Moreover Xbp1CartDEx2
growth plates are marked by shortening of the growth plate hy-
pertrophic zone and dysregulated chondrocyte proliferation. This is
the first study to implicate the IRE1/XBP1 signaling pathway in
cartilage development in vivo, and suggests hitherto unknown
physiological functions for IRE1/XBP1 signaling in development.
Methods
Generation of mice with cartilage-specific Xbp1 inactivation
Mice harboring loxP sites flanking exon 2 of Xbp18 were crossed
with a transgenic mouse expressing Cre recombinase driven by the
Col2a1 promoter9 to generate Xbp1flox/flox.Col2a1-Cre (Xbp1CartDEx2),
in which Xbp1 mRNA is inactivated by Cre recombinase-mediateddeletion of exon 2 in chondrocytes. Xbp1 exon 2 deletion results
in complete ablation of XBP1 protein but does not prevent IRE1-
induced Xbp1 mRNA splicing as an ER-stress reporter10. These
mice were viable and bred normally, and were housed under
pathogen-free conditions. Studies were performed with Institu-
tional Ethics Committee approval and according to NIH guidelines
for humane animal use. Genomic DNA (gDNA) was extracted by
Proteinase K digestion of tail clips for genotyping, and purified by
isopropanol precipitation. Genotyping was performed by PCR using
primers to detect the presence of floxed Xbp1 or Col2a1-Cre
recombinase (PCR details available on request). To assess Xbp1
inactivation in Xbp1CartDEx2 cartilage, RT-PCR was performed on
wildtype and mutant epiphyseal cartilage cDNA with primers
flanking Xbp1 exon 2. PCR products were sequenced using the
BigDye Terminator v3.1 Cycle Sequencing Kit (Life Technologies) to
confirm deletion of Xbp1 exon 2 in Xbp1CartDEx2 chondrocytes.
Skeletal preparations and morphometry
Mouse skeletons were analyzed morphometrically following
Alcian blue and Alizarin red staining as described11. Femoral and
tibial lengths were used to indicate endochondral bone growth, and
intercanthal distance (ICD) to measure intramembranous bone
growth12. X-ray images were prepared as described12.
Immunofluorescence and histology
Immunofluorescence and histology was performed on PFA-fixed
10 mm cryosections or 5 mm paraffin-embedded sections of prox-
imal tibial epiphyses from Xbp1CartDEx2 or wildtype mice. Immu-
nofluorescence was performed using mouse anti-mouse collagen II
(6B3, Neomarkers) rabbit anti-human collagen X, or rabbit anti-
human IHH (EP1192Y, Abcam) and appropriate fluorescent sec-
ondary antibodies (10 mg/ml; Molecular Probes, Life Technologies).
Rabbit polyclonal collagen X antibodies were produced using His6-
tagged full length human collagen X cDNA purified from trans-
fected 293-EBNA cells13. Prior to antigen retrieval, all sections were
incubated for 10min at room temperature in PBS, 0.2% Triton X-100
(SigmaeAldrich). For collagen II antigen retrieval, sections were
digested for 10e15 min at 37C in 2 mg/ml porcine pepsin (Sigma
Aldrich). For collagen X antigen retrieval, sections were digested for
10e15 min at 37C in 2 mg/ml bovine hyaluronidase (Sigma
Aldrich). Collagen II staining was performed using reagents from
the VECTOR M.O.M. Immunodetection Basic Kit (Vector Labora-
tories, Inc). All immunofluorescence sections were counterstained
and mounted using VECTASHIELD Mounting Medium with DAPI
(Vector Laboratories, Inc), and visualized using an Axio Imager M1
fluorescent microscope (Zeiss). Hematoxylin and eosin (H&E)
staining was performed following a standard protocol involving
staining in hematoxylin for 5 min and eosin for 1 min. Toluidine
blue staining was performed using a standard protocol involving
10 min immersion in Toluidine blue and a 3 min counterstain in
Fast Green. Staining for tissue mineralization was performed using
standard protocols for Alizarin Red or Von Kossa stains.
Cell death and proliferation assays
Bromodeoxyuridine (BrdU) labeling analysis was performed by
injecting Cell Proliferation Labeling Reagent (Amersham) perito-
neally to detect growth plate chondrocyte proliferation14. Terminal
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) was
performed with the In Situ Cell Death Detection Kit, Fluorescein
(Roche) to detect DNA fragmentation in cells undergoing pro-
grammed cell death14.
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Primary chondrocytes from femoral and tibial condyles of 3 day
old Xbp1CartDEx2 mice were isolated as described15 and cultured
overnight at a concentration of approximately 1.0 105 cells/cm2 in
Dulbecco's modified Eagle's medium (DMEM), 10% fetal bovine
serum (Thermo Fisher Scientific) supplemented with 1 mg/ml
penicillin and 0.1 mg/ml streptomycin (Sigma Aldrich) at 37C
under 95% air, 5% CO2. Media was replaced the following day with
fresh media, with or without 2.5 ng/ml tunicamycin (Sigma
Aldrich), and cultures were incubated for a further 4 h. RNA was
extracted using the RNeasy Mini Kit (Qiagen).Fig. 1. Genetic and morphometric characterization of Xbp1CartDEx2 mice. (A,B) cDNA fromwil
full-length form of Xbp1 (FL) or the inactive form of Xbp1 lacking exon 2 (DEx2), and (B) s
Overall skeletal development assessed by (C) whole mount Alizarin red S/Alcian blue stainin
and (D) X-ray analysis of 3 week Wt and Xbp1CartDEx2 mice. (E) Measurements of femoral and
Wt, N ¼ 8; Xbp1CartDEx2, N ¼ 9.Microdissection of growth plate zones, RNA isolation and
amplification
Growth plate zones were microdissected from one proximal
tibial growth plate from each of three 2 week old Xbp1CartDEx2 and
wildtype mice as described previously16. RNA was extracted from
microdissected tissues using TRIzol reagent (Invitrogen). All total
RNA samples were subjected to two rounds of linear amplification
using the RNA ampULSe Amplification Kit (Kreatech). We have
previously validated that this method preserves the relative
abundance of transcripts present in cartilage total RNA
samples16e18. Purity and integrity of all RNA samples weredtype (Wt) and Xbp1CartDEx2 femoral head cartilage analyzed by (A) RT-PCR to detect the
equencing to confirm the deletion of exon 2 from Xbp1 in Xbp1CartDEx2 cartilage. (C,D)
g of skeletal preparations from 3 day old, 1 week, and 2 week Wt and Xbp1CartDEx2 mice,
tibial length, and intercanthal distance (ICD) from 2 week Wt and Xbp1CartDEx2 mice e
Fig. 2. XBP1 controls growth plate structure and mineralization. (AeF) Tibial epiphyseal cryosections from 2 week wildtype (Wt) and Xbp1CartDEx2 mice stained (A,B) with he-
matoxylin and eosin (H&E) and by immunofluorescence for (C,D) collagen II and (E,F) collagen X. (G) Quantitative analysis of growth plate zone lengths from H&E-stained tibial
cryosections of 2 weekWt and Xbp1CartDEx2 mice. (HeK) Tibial epiphyseal cryosections from 2 weekWt and Xbp1CartDEx2 mice stained with (H,I) Alizarin Red or (J,K) Von Kossa stain.
(LeS) Tibial cryosections from E15.5 Wt and Xbp1CartDEx2 embryos stained with (L,M) H&E, (N,O) Toluidine Blue, (P,Q) Alizarin Red, or (R,S) by immunofluorescence for collagen X. B
e bone, HZ e hypertrophic zone, PZ e proliferative zone, RZ e resting zone, SCO e secondary center of ossification.
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Sensitivity R6K Screen Tape Kit (Agilent Technologies).
Quantitative PCR (qPCR) analysis
For Xbp1 splicing, RT-PCR was performed on equal quantities of
cDNA using primers flanking the ER stress-responsive Xbp1 splice
site. qPCR was performed on equal quantities of cDNA using the
LightCycler 480 Probes Master Kit on a LightCycler 480 II qPCR
machine (Roche Applied Science) as described16. All primer se-
quences are available on request.
Statistical methods
All quantitative data were generated using biological replicates
in triplicate, unless stated otherwise, and are expressed as the
mean plus 95% confidence interval. In each case, P values were
determined using the unpaired Student's t test. All analyses were
conducted using GraphPad QuickCalcs software (La Jolla, CA, USA).
Results
Xbp1CartDEx2 mice exhibit mild dwarfism and delayed ossification
RT-PCR analysis and sequencing confirmed deletion of exon 2
from Xbp1 mRNA in Xbp1CartDEx2 but not wildtype cartilages
[Fig.1(A),(B)].WhenXbp1CartDEx2 andwildtypemicewere compared
by Alcian blue/Alizarin red staining of skeletal preparations or X-
rays, themutants exhibitedmild dwarfism [Fig.1(C),(D)]. At 2weeks
of age, endochondral bones in mutant mice were shortened by
approximately 13% compared with wildtype, but no difference was
observed in ICD betweenmutant andwildtype [Fig.1(E)], indicating
that intramembranous bone formation was unaffected. By 7 weeksFig. 3. XBP1 regulates proliferative zone architecture and chondrocyte proliferation. (A) R
column length in wildtype (Wt) and Xbp1CartDEx2 proliferative zones. Arrows in (A) indica
represented in (A). (C) Representative images of BrdU analysis to assess chondrocyte prolif
resented in (C). HZ e hypertrophic zone, PZ e proliferative zone, RZ e resting zone, SCO eof age, no difference was observed between wildtype and Xbp1Cart-
DEx2 in the length of endochondral bones (Fig. S1(A)). Thus
Xbp1CartDEx2 mice exhibited a mild chondrodysplasia during devel-
opment that resolved by skeletal maturity.
Histological analysis of endochondral ossification revealed
important clues to the Xbp1CartDEx2 phenotype. H&E staining of
2 week growth plates suggested delayed development of the sec-
ondary ossification center and hypertrophic zone shortening in
mutant vs wildtype [Fig. 2(A),(B)]. Hypertrophic zone shortening
was confirmed by collagen X immunofluorescence in adult
[Fig. 2(E),(F)] and embryonic tissues [Fig. 2(R),(S)]. Growth plate
zone lengths were also quantified in 2 week old mice using H&E-
stained tissues. This revealed an approximately 45% reduction in
hypertrophic zone length and a modest reduction in resting zone
length in Xbp1CartDEx2 vs wildtype at 2 weeks of age [Fig. 2(G)]; no
differences were apparent in growth plate zone length between
wildtype and mutant at 7 weeks of age (Fig. S1(B)). Delayed
mineralization of Xbp1CartDEx2 endochondral bones during devel-
opment was confirmed in 2 week old [Fig. 2(H)e(K)] and embry-
onic tissues [Fig. 2(P),(Q)] by Alizarin Red or Von Kossa staining.
Finally, that no apparent difference in the secretion or deposition of
either collagen II or collagen Xwas apparent by immunofluorescent
analysis of Xbp1CartDEx2 cartilage vs wildtype [Fig. 2(C)e(F)] sug-
gests that neither cartilage matrix assembly, nor chondrocyte hy-
pertrophy depend on XBP1 signaling in cartilage development.
Chondrocyte proliferation is dysregulated in the Xbp1CartDEx2 growth
plate but cell death is not
H&E staining of 2 week tibial growth plate sections revealed
architectural differences between the Xbp1CartDEx2 and wildtype
proliferative zones, with longer chondrocyte columns and
increased prevalence and size of areas of hypocellularity in theepresentative images of hematoxylin and eosin (H&E) staining to assess chondrocyte
te areas of hypocellularity. (B) Quantification of chondrocyte column length analysis
eration in Wt and Xbp1CartDEx2 growth plates. (D) Quantification of BrdU analysis rep-
secondary center of ossification.
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ation in the mutant [Fig. 3(A),(B)]. BrdU analysis of Xbp1CartDEx2 and
wildtype growth plates demonstrated a modest reduction in
chondrocyte proliferation in the Xbp1CartDEx2 proliferative zone
compared with wildtype (P ¼ 0.026; Fig. 3(C),(D)).
To investigate the proliferative defect at the transcriptional
level, we microdissected proliferative and hypertrophic zones from
Xbp1CartDEx2 and wildtype mice. Expression profiling was per-
formed by qPCR for the following genes implicated in chondrocyte
proliferation: Atf219, Atf320, Ccna221, Ccnd122, Fgfr323, and Ihh, which
regulates chondrocyte proliferation from its site of expression in
the hypertrophic zone24 [Fig. 4(A)e(F)]. None of these genes were
differentially expressed between Xbp1CartDEx2 and wildtype except
for Ccnd1, which appeared to be upregulated approximately 2-fold
in the proliferative zone of Xbp1CartDEx2 compared to wildtype
(P¼ 0.038). Since IHH regulates both chondrocyte proliferation and
bone collar formation25, both of which were dysregulated in
Xbp1CartDEx2, we confirmed IHH expression in the mutant by
immunofluorescence [Fig. 4(G)e(J)]. IHH was detected at compa-
rable levels in proliferating chondrocytes in wildtype vs mutant in
both E15.5 tibiae and 2 week tibial growth plates. IHH was alsoFig. 4. Expression profiling of chondrocyte proliferation markers in developing Wt and X
wildtype (Wt) and Xbp1CartDEx2 growth plate zones as indicated, using primers specific for
rescence in (G,H) E15.5 Wt and Xbp1CartDEx2 proximal tibial epiphyses, and in (I,J) two week
positions of original images used to generate composite images as shown. B e bone, BC e b
secondary center of ossification.detected in the developing bone collar of wildtype E15.5 tibiae,
which was absent from E15.5 Xbp1CartDEx2 tibiae.
TUNEL analysis was performed on Xbp1CartDEx2 and wildtype
growth plates (Fig. S2) to examine chondrocyte cell death in the
mutants. No significant changes in the ratio of TUNEL-positive
cells:DAPI-stained nuclei were apparent in the Xbp1CartDEx2
resting, proliferative, or hypertrophic zones by comparison with
their corresponding wildtype zones. Thus cell death is unlikely to
contribute to the mutant phenotype.
A classical UPR is not activated in the Xbp1CartDEx2 growth plate
We investigated the UPR in Xbp1CartDEx2 chondrocytes by testing
their response to ER stress in vitro, and by performing expression
profiling using themicrodissectedXbp1CartDEx2 andwildtype growth
plate zones (Fig. 5). Increased Xbp1 splicing and BiP upregulation
were observed in primary Xbp1CartDEx2 chondrocytes cultured in
tunicamycin compared to control cultures, demonstrating that the
UPR is not intrinsically compromised in Xbp1CartDEx2 cartilage
[Fig. 5(A),(B)]. In the growth plate, sentinel markers of the chon-
drocyte UPR16 were examined. BiPwasmodestly upregulated in thebp1CartDEx2 long bones. (AeF) qPCR performed on cDNA derived from microdissected
(A) Atf2, (B) Atf3, (C) Ccna2, (D) Ccnd1, (E) Fgfr3, and (F) Ihh. (GeJ) IHH immunofluo-
Wt and Xbp1CartDEx2 tibial growth plates. Dashed lines in (G) and (H) indicate relative
one collar, HZ e hypertrophic zone, PZ e proliferative zone, RZ e resting zone, SCO e
Fig. 5. XBP1 is not required by chondrocytes to maintain ER homeostasis. (A) RT-PCR performed on cDNA derived from primary Xbp1CartDEx2 chondrocytes following culture with
(þTm) or without (Tm) tunicamycin to detect the unspliced (Xbp1U) and spliced (Xbp1S) forms of Xbp1 in response to ER stress. Xbp1H denotes a heteroduplex product comprised
of both Xbp1U and Xbp1S strands. (B) qPCR performed on the þTm and Tm cDNA described in (A) to assess differential expression of BiP in Xbp1CartDEx2 cartilage following induction
of ER stress. (CeF) qPCR performed on cDNA derived from microdissected wildtype (Wt) and Xbp1CartDEx2 growth plate zones, using primers specific for (C) BiP, (D) Creld2, (E) Derl3,
and (F) Luman. PZ e proliferative zone, HZ e hypertrophic zone.
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hypertrophic zone [Fig. 5(C)]. Differential expression was not
observed however for Creld2 [Fig. 5(D)] or Derl3 [Fig. 5(E)] in either
zone between mutant and wildtype. Luman was upregulated in
Xbp1CartDEx2 vs wildtype in both the proliferative and hypertrophic
zones [Fig. 5(F)]. Thus Xbp1CartDEx2 chondrocytes can respond to ER
stress, however ablation of XBP1 activity does not result in activa-
tion of a classical UPR in vivo.IRE1 is hyperactivated in the Xbp1CartDEx2 growth plate but does not
cause RIDD
Xbp1 splicing analysis of Xbp1CartDEx2 primary chondrocytes
indicated that significant Xbp1 splicing occurs in untreated cells
[Fig. 5(A)], revealing that IRE1 hyperactivation via a feedback loop
previously reported in XBP1-deficient pancreatic b-islet cells26 also
occurs in Xbp1CartDEx2 chondrocytes in vitro. To confirm whether
IRE1 is hyperactivated in the Xbp1CartDEx2 growth plate, we inves-
tigated Xbp1 splicing in Xbp1CartDEx2 and wildtype growth plate
zones [Fig. 6(A)]. In the wildtype proliferative zone, most Xbp1
transcripts were Xbp1U, however low levels of Xbp1S were also
detectable. In the wildtype hypertrophic zone, only Xbp1U tran-
scripts were detectable. In Xbp1CartDEx2, most Xbp1 transcripts in
both zones were Xbp1S, confirming in vivo hyperactivation of IRE1
in Xbp1CartDEx2 chondrocytes.
To determine whether IRE1 hyperactivation induces RIDD, we
assayed RIDD by qPCR using four established mammalian RIDD
marker genes5: Scara3, Hgsnat, Blos1 and Pdgfrb. Firstly, we inter-
rogated primary Xbp1CartDEx2 chondrocytes cultured with or
without tunicamycin [Fig. 6(B)e(E)], to confirm whether RIDD is
induced in Xbp1CartDEx2 chondrocytes under ER stress. Scara3 was
significantly downregulated in tunicamycin-treated Xbp1CartDEx2chondrocytes compared to untreated controls. Downregulation of
Hgsnat (P ¼ 0.017) and Blos1 (P ¼ 0.053) was also apparent in
tunicamycin-treated Xbp1CartDEx2 chondrocytes compared to un-
treated controls, but only modestly so. This however, is broadly
consistent with previous work indicating that the scale of transcript
degradation resulting from chemically induced ER stress in
mammalian cells is frequently substantially smaller than has been
observed in Drosophila cells5. We could not detect differential
expression of Pdgfrb in tunicamycin-treated Xbp1CartDEx2 chon-
drocytes compared with untreated controls. Overall however, these
results suggest that Xbp1CartDEx2 chondrocytes are capable of acti-
vating RIDD and degrading target transcripts.
qPCR was performed for our panel of RIDD markers onwildtype
or Xbp1CartDEx2 proliferative zones [Fig. 6(F)e(I)] as well as wildtype
or Xbp1CartDEx2 hypertrophic zones [Fig. 6(J)e(M)]. Except for Blos1
in the hypertrophic zone, we could not detect depletion of any of
the transcripts in either growth plate zone from Xbp1CartDEx2
compared with the corresponding zone fromwildtype. Thus, while
Xbp1CartDEx2 chondrocytes can induce RIDD, they appear not to do
so as a consequence of IRE1 hyperactivation. Therefore, we could
exclude RIDD-mediated dysregulation of growth plate gene
expression as a factor contributing to the Xbp1CartDEx2 phenotype.Discussion
We analyzed Xbp1CartDEx2mice, inwhich XBP1 activity is ablated
from cartilage. Previous studies involving differentiation of chon-
drogenic cell lines in vitro suggested an essential role for XBP1 in
controlling chondrocyte hypertrophy by acting co-ordinately with
RUNX2 and regulating Pthrp, Ihh, Runx2, Col2a1, and Col10a1
expression7. Our studies show that in themore complex situation of
cartilage development in vivo, XBP1 is not required for chondrocyte
Fig. 6. RIDD is activated in Xbp1CartDEx2 chondrocytes in response to ER stress but not IRE1 hyperactivation. (A) RT-PCR performed on cDNA derived from growth plate zones
microdissected from two week wildtype (Wt) and Xbp1CartDEx2 tibiae to detect the unspliced (Xbp1U) and spliced (Xbp1S) forms of Xbp1 in response to ER stress. Xbp1H denotes a
heteroduplex product comprised of both Xbp1U and Xbp1S strands. (BeM) qPCR performed using primers specific for (B,F,J) Scara3, (C,G,K) Hgsnat, (D,H,L) Blos1, and (E,I,M) Pdgfrb, on
cDNA derived from (B,C,D,E) primary Xbp1CartDEx2 chondrocytes following culture with (þTm) or without (Tm) tunicamycin, (F,G,H,I) microdissected Wt and Xbp1CartDEx2 pro-
liferative zones, and (J,K,L,M) microdissected Wt and Xbp1CartDEx2 hypertrophic zones. HZ e hypertrophic zone, PZ e proliferative zone.
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drodysplasia during skeletal development involving disorganized
proliferative zone architecture, hypertrophic zone shortening, and
delayed mineralization of endochondral bones.
Although we could not detect a significant difference between
the length of the proliferative zone in Xbp1CartDEx2 andwildtype, the
chondrocyte columns of the proliferative zone were significantly
longer in themutant than inwildtype at 2 weeks of age, hinting at a
role for the XBP1 pathway in chondrocyte proliferation. This was
confirmed by BrdU analysis showing mild impairment of chon-
drocyte proliferation in the Xbp1CartDEx2 growth plate. PTHrP in-
hibits chondrocyte differentiation and promotes chondrocyte
proliferation in the growth plate in a feedback loop involving IHH24.
Thus, defective IHH/PTHrP signaling could explain the reduced
chondrocyte proliferation we observed in the Xbp1CartDEx2 growth
plate. However, differential expression consistent with reduced
chondrocyte proliferation was not detected for key markers of this
process, including IHH. The only chondrocyte proliferation marker
found to be significantly differentially expressed was Ccnd1, which
appeared to be modestly upregulated in the mutant proliferativezone. Previouswork however, suggests that increased expression of
Ccnd1 in chondrocytes promotes, rather than inhibits their prolif-
eration22. Alternatively, our data may point to a role for XBP1 in
regulating the activity of integrins or integrin-linked kinase, since
disruption to integrin-dependent interactions between chon-
drocytes and the growth plate matrix are known to result in
chondrodysplasias characterized by disrupted proliferative zone
architecture27,28. Regardless of the precise mechanism involved,
our data emphasize for the first time the importance of the XBP1
pathway in regulating the organization and function of growth
plate proliferative chondrocytes.
IRE1 was hyperactivated in Xbp1CartDEx2 chondrocytes, raising
the possibility that the Xbp1CartDEx2 phenotype may result from loss
of XBP1 activity, IRE1 hyperactivation, or both. A potential conse-
quence of IRE1 hyperactivation in Xbp1CartDEx2 is dysregulation of
growth plate gene expression through RIDD5,29. Analysis of
mammalian markers of RIDD5 revealed that while ER stress is
sufficient to trigger RIDD in Xbp1CartDEx2 chondrocytes, IRE1
hyperactivation alone is not, excluding RIDD from the Xbp1CartDEx2
growth plate pathology. These data also indicate differences in the
T.L. Cameron et al. / Osteoarthritis and Cartilage 23 (2015) 661e670 669activation of IRE1 by ER stress vs hyperactivation, exposing a
further layer of complexity in IRE1 activation to that already
reported5.
Xbp1CartDEx2 chondrocytes activated a UPR in response to ER
stress, although a classical UPRwas not observed in the Xbp1CartDEx2
growth plate. Intriguingly, Lumanwas upregulated strongly in both
the mutant proliferative and hypertrophic zones compared with
wildtype. LUMAN is structurally and functionally homologous to
ATF630, and can upregulate UPR target genes in response to ER
stress31. The significance of Luman upregulation in Xbp1CartDEx2
chondrocytes is unclear. Our work implies however, that it does not
depend on classical ER stress. Rather, Luman expression may be
induced by IRE1 in an XBP1-independent manner following either
ER stress or IRE1 hyperactivation.
The chondrodysplasia in Xbp1CartDEx2 mice is mild, involving a
generalized delay in endochondral ossification rather than the
complete blockage in chondrocyte hypertrophy predicted by recent
in vitro studies7. Indeed, by 7 weeks of age no difference was
apparent between wildtype and Xbp1CartDEx2 in terms of the length
of endochondral bones or growth plate morphology. This implies a
role for XBP1 in regulating the timing of endochondral ossification
rather than directing chondrocyte differentiation per se. In contrast,
the dwarfism phenotype is severe in both the Bbf2h7 and Atf4 null
mice, due to disrupted protein trafficking and IHH signaling,
respectively2,4. These differences highlight how endochondral
ossification may be regulated by components of ER stress-
responsive pathways through a variety of mechanisms.
Finally, we note that activation of XBP1 signaling has been re-
ported as a component of the pathological destruction of cartilage
in human and animal models of osteoarthritis (OA)32,33, a disease
characterized by re-activation of chondrocyte proliferation, differ-
entiation and hypertrophy programs34. Our work provides links
between XBP1 and each of these aspects of chondrocyte biology
in vivo, by implying that it promotes chondrocyte proliferation and
regulates the timing of cartilage maturation and biomineralization.
Future studies will address the role of the XBP1 pathway in the
pathology of OA by investigating the progression of joint pathology
in Xbp1CartDEx2 mice following destabilization of the medial
meniscus.
In conclusion, we have demonstrated that XBP1 regulates
chondrocyte proliferation and the timing of cartilage maturation
and matrix mineralization during endochondral ossification. This
study is the first to analyze the function of XBP1 in growth plate
cartilage, and extends our understanding of how key UPR compo-
nents interact with molecular pathways controlling physiological
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